Talis Capital

Portfolio · 3

Immunai

Peripheral Tissue Analysis

1 round $215.0M committed Latest: 2021-10

Cyber Observer

Cyber-security Management and Awareness

1 round $3.0M committed Latest: 2017-07

Clicktale

Experience Analytics

1 round $17.0M committed Latest: 2013-05

Investment activity

2 portfolio exits on record.

Q&A

What is Talis Capital's most recent exit?

Talis Capital exited Cyber Observer in June 2022 when it was acquired by XM Cyber.

Which sectors does Talis Capital focus on for its portfolio companies?

Talis Capital's portfolio includes companies in Business Software.

Can you name a notable investment by Talis Capital in the Health Tech & Life Sciences sector?

Talis Capital invested in Immunai, a company focused on Peripheral Tissue Analysis, which raised a B round of $295M.

What was Talis Capital's earliest recorded exit?

Talis Capital exited Clicktale in July 2019 when it was acquired by Contentsquare.

What is the typical investment range for Talis Capital?

Talis Capital's investment range is between $3M and $215M.

How many investment rounds has Talis Capital participated in over the last few years?

Talis Capital participated in one investment round in May 2013, one in July 2017, and one in October 2021.

What type of funding stages does Talis Capital typically participate in?

Talis Capital has participated in A Round and B Round funding stages.